v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue    
Total revenue $ 5,674 $ 4,144
Cost of revenue 4,047 2,545
Gross profit 1,627 1,599
Operating expenses:    
Acquired in-process research and development 2,717 0
Research and development 12,358 3,139
Selling, general and administrative 46,923 24,814
Total operating expenses 61,998 27,953
Loss from operations (60,371) (26,354)
Other income (expense):    
Foreign exchange transaction (loss) gain (135) 70
Change in fair value of share liability (121) (132)
Change in fair value of convertible notes payable (123,719) (6,875)
Change in fair value of investments 580 0
Interest income 6,790 1,238
Interest expense (327) (259)
Other income 6 0
Total other expense (116,926) (5,958)
Loss before income tax expense (177,297) (32,312)
Income tax expense (88) (111)
Net loss from continuing operations (177,385) (32,423)
Income from discontinued operations, net of taxes 17,542 0
Net loss (159,843) (32,423)
Less: Net income (loss) attributable to noncontrolling interests 15,249 (89)
Net loss attributable to ASP Isotopes Inc. shareholders before deemed dividend on inducement warrant for common stock (175,092) (32,334)
Deemed dividend on inducement warrant for common stock 0 (2,780)
Net loss attributable to ASP Isotopes Inc. shareholders $ (175,092) $ (35,114)
Net (loss) income per share, basic and diluted    
Net (loss) income per share, basic, Continuing operations $ (2.14) $ (0.58)
Net (loss) income per share, diluted, Continuing operations (2.14) (0.58)
Net (loss) income per share, basic, Discontinued operations 0.21 0
Net (loss) income per share, diluted, Discontinued operations 0.21 0
Net (loss) income per share, attributable to ASP Isotopes Inc. shareholders, basic (2.11) (0.63)
Net (loss) income per share, attributable to ASP Isotopes Inc. shareholders, diluted $ (2.11) $ (0.63)
Weighted average shares of common stock outstanding, basic 83,013,594 55,671,805
Weighted average common stock outstanding, diluted 83,013,594 55,671,805
Comprehensive loss:    
Net loss before allocation to noncontrolling interests $ (159,843) $ (32,423)
Foreign currency translation 4,706 (1,243)
Total comprehensive loss before allocation to noncontrolling interests (155,137) (33,666)
Less: Comprehensive income (loss) attributable to noncontrolling interests 15,659 (119)
Comprehensive loss attributable to ASP Isotopes Inc. (170,796) (33,547)
Product Revenue [Member]    
Revenue    
Total revenue 5,674 3,944
Collaboration Revenue [Member]    
Revenue    
Total revenue $ 0 $ 200